Evidence map›Paper›PMID 30005605›Full record

ArticleBMC genomics2018

Expression profile analysis reveals that Aspergillus fumigatus but not Aspergillus niger makes type II epithelial lung cells less immunological alert.

Natalia Escobar, Ivan D Valdes, Esther M Keizer, Soledad R Ordonez, Robin A Ohm, Han A B Wösten, Hans de Cock

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Accelerating the understanding ofCurrent research in microbial sciences · 2024
    Review
  3. Article
  4. Review
  5. Article
  6. Distinct Cohorts ofFrontiers in cellular and infection microbiology · 2022
    Article
  7. Article
  8. EphA2-Dependent Internalization ofFrontiers in microbiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Natalia EscobarMicrobiology & Institute of Biomembranes, Department of Biology, Utrecht University, Padualaan 8, 3584 CH, Utrecht, The Netherlands.
Ivan D ValdesMicrobiology & Institute of Biomembranes, Department of Biology, Utrecht University, Padualaan 8, 3584 CH, Utrecht, The Netherlands.
Esther M KeizerMicrobiology & Institute of Biomembranes, Department of Biology, Utrecht University, Padualaan 8, 3584 CH, Utrecht, The Netherlands.
Soledad R OrdonezDepartment of Infectious Diseases and Immunology, Division Molecular Host Defence, Utrecht University, Yalelaan 1, 3584CL, Utrecht, The Netherlands.
Robin A OhmMicrobiology & Institute of Biomembranes, Department of Biology, Utrecht University, Padualaan 8, 3584 CH, Utrecht, The Netherlands.
Han A B WöstenMicrobiology & Institute of Biomembranes, Department of Biology, Utrecht University, Padualaan 8, 3584 CH, Utrecht, The Netherlands.
Hans de CockMicrobiology & Institute of Biomembranes, Department of Biology, Utrecht University, Padualaan 8, 3584 CH, Utrecht, The Netherlands. h.decock@uu.nl.ORCID http://orcid.org/0000-0002-8420-6764
Utrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAspergillus fumigatus is the main causative agent of aspergillosis. Infections rarely occur in immunocompetent individuals, indicating efficient clearance of conidia by pulmonary defense mechanisms. Other aspergilli like Aspergillus niger also cause infections but to a much lesser extent. Our previous studies showed that A. fumigatus and A. niger have different behavior in the presence of type II alveolar A549 epithelial cells. A. fumigatus conidia are more efficiently internalized by these cells and germination is delayed when compared to A. niger. In addition, hyphae that have escaped the epithelial cells grow parallel to the epithelium, while A. niger grows away from this cell layer.

resultsHere it is shown that global gene expression of A. fumigatus and A. niger is markedly different upon contact with A549 cells. A total of 545 and 473 genes of A. fumigatus and A. niger, respectively, were differentially expressed when compared to growth in the absence of A549 cells. Notably, only 53 genes (approximately 10%) were shared in these gene sets. The different response was also illustrated by the fact that only 4 out of 75 GO terms were shared that were enriched in the differentially expressed gene sets. The orthologues of A. fumigatus genes involved in hypoxia regulation and heat shock were also up-regulated in A. niger, whereas thioredoxin reductase and allergen genes were found up-regulated in A. fumigatus but down-regulated in A. niger. Infection with A. fumigatus resulted in only 62 up and 47 down-regulated genes in A549. These numbers were 17 and 34 in the case of A. niger. GO terms related with immune response were down-regulated upon exposure to A. fumigatus but not in the case of A. niger. This indicates that A. fumigatus reprograms A549 to be less immunologically alert.

conclusionsOur dual transcriptomic analysis supports earlier observations of a marked difference in life style between A. fumigatus and A. niger when grown in the presence of type II epithelial cells. The results indicate important differences in gene expression, amongst others down regulation of immune response genes in lung epithelial cells by A. fumigatus but not by A niger.

Indexed as

A549 CellsAspergillus fumigatusAspergillus nigerDown-RegulationEpithelial CellsGene Expression ProfilingHost-Pathogen InteractionsHumansInterleukin-8RNASequence Analysis, RNAUp-RegulationInterleukin-8RNAA. fumigatusA. nigerAspergillosisEpithelial cellsHost-microbe interaction

Identifiers

PMID30005605
PMCPMC6044037
OpenAlexW2884869999

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.